DK0594613T3 - Syntetiske peptider fra human papillomavirus 1, 6, 11, 16, 31, 33 og 56, der er nyttige i immunoassays til diagnostiske formål - Google Patents

Syntetiske peptider fra human papillomavirus 1, 6, 11, 16, 31, 33 og 56, der er nyttige i immunoassays til diagnostiske formål

Info

Publication number
DK0594613T3
DK0594613T3 DK91909813.7T DK91909813T DK0594613T3 DK 0594613 T3 DK0594613 T3 DK 0594613T3 DK 91909813 T DK91909813 T DK 91909813T DK 0594613 T3 DK0594613 T3 DK 0594613T3
Authority
DK
Denmark
Prior art keywords
immunoassays
useful
synthetic peptides
diagnostic purposes
human papillomavirus
Prior art date
Application number
DK91909813.7T
Other languages
English (en)
Inventor
Joakim Dillner
Lena Dillner
Hwee-Ming Cheng
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Application granted granted Critical
Publication of DK0594613T3 publication Critical patent/DK0594613T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK91909813.7T 1990-05-11 1991-05-13 Syntetiske peptider fra human papillomavirus 1, 6, 11, 16, 31, 33 og 56, der er nyttige i immunoassays til diagnostiske formål DK0594613T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001705A SE9001705D0 (sv) 1990-05-11 1990-05-11 Saett foer diagnostik av virusbaerande tumoerer genom immunoassay

Publications (1)

Publication Number Publication Date
DK0594613T3 true DK0594613T3 (da) 1998-06-02

Family

ID=20379456

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91909813.7T DK0594613T3 (da) 1990-05-11 1991-05-13 Syntetiske peptider fra human papillomavirus 1, 6, 11, 16, 31, 33 og 56, der er nyttige i immunoassays til diagnostiske formål

Country Status (10)

Country Link
EP (1) EP0594613B1 (da)
JP (1) JPH06501542A (da)
AT (1) ATE160020T1 (da)
AU (1) AU668499B2 (da)
CA (2) CA2040849A1 (da)
DE (1) DE69128152T2 (da)
DK (1) DK0594613T3 (da)
FI (1) FI925098A7 (da)
SE (1) SE9001705D0 (da)
WO (1) WO1991018294A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2193133T3 (es) * 1991-07-13 2003-11-01 Dade Behring Marburg Gmbh Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines.
DE4123760C2 (de) * 1991-07-18 2000-01-20 Dade Behring Marburg Gmbh Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
DE4415743C2 (de) * 1994-05-04 1996-10-10 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
DE4430601A1 (de) * 1994-08-22 1996-02-29 Beiersdorf Ag Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander
SE9501512D0 (sv) * 1995-04-24 1995-04-24 Euro Diagnostica Ab Synthetic peptide-defined eptopes useful for vaccination against papillomavirus
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
AUPO390396A0 (en) * 1996-11-29 1996-12-19 Csl Limited Novel promiscuous T helper cell epitopes
GB9718745D0 (en) * 1996-12-03 1997-11-12 Medical Res Council Improvements in or relating to screening for carcinoma
DE19812940A1 (de) * 1998-03-24 1999-10-07 Medigene Ag Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung
US6284532B1 (en) * 1998-08-17 2001-09-04 Indiana University Purified human papillomavirus
DE19925235A1 (de) 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
DE19925199A1 (de) 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
US6699466B1 (en) * 1999-08-05 2004-03-02 Research Corporation Technologies, Inc. IL-16 antagonist peptides and DNA encoding the peptides
CA2384987A1 (en) * 1999-09-16 2001-03-22 Zycos Inc. Nucleic acids encoding polyepitope polypeptides
US7026443B1 (en) 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
CN1433428A (zh) * 2000-04-05 2003-07-30 冲击诊断公司 辨别人乳头瘤病毒的免疫学方法
AU2002219711B8 (en) * 2000-12-08 2006-03-02 Academisch Ziekenhuis Leiden Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
US6933123B2 (en) 2001-04-05 2005-08-23 Yao Xiong Hu Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
PL1576967T3 (pl) 2004-03-18 2008-03-31 Pasteur Institut Rekombinowane białko niosące epitopy ludzkiego wirusa brodawczaka wstawione w białko cyklazy adenylanowej lub jego fragment oraz jego zastosowania terapeutyczne
ES2309785T3 (es) 2004-08-13 2008-12-16 F. Hoffmann-La Roche Ag Modificacion c-terminal de polipeptidos.
CN103940993A (zh) * 2013-01-23 2014-07-23 艾托金生物医药（苏州）有限公司 用于检测抗人乳头瘤病毒抗体的抗原及试剂盒和应用
CN104004067B (zh) * 2013-02-22 2017-09-01 艾托金生物医药（苏州）有限公司 用于检测抗人乳头瘤病毒抗体的抗原及相关免疫检测试剂盒
CN106892967A (zh) * 2015-12-17 2017-06-27 中国科学院苏州纳米技术与纳米仿生研究所 用于检测宫颈癌的多肽、检测器件和检测试剂盒
WO2019145792A1 (en) * 2018-01-24 2019-08-01 The Council Of The Queensland Institute Of Medical Research Hpv immunotherapy
MA52363A (fr) * 2018-04-26 2021-03-03 Agenus Inc Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation
CN118243929B (zh) * 2024-05-30 2024-08-13 弗雷米德生物医药技术（天津）有限公司 一种用于宫颈癌癌前病变和癌变检测的联检试剂盒及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2524487B1 (fr) * 1982-04-05 1985-11-22 Pasteur Institut Fragments d'adn codant pour des polypeptides contenant au moins un determinant antigenique des papillomavirus, notamment du type hpv 1a et polypeptides correspondants
FR2586428B1 (fr) * 1985-08-26 1988-11-25 Pasteur Institut Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro, a la prevention et/ou la lutte contre des infections a papillomavirus
ATE76429T1 (de) * 1986-03-21 1992-06-15 Pasteur Institut Bestimmte, von einem papillomavirus-genom abgeleitete dns-sequenzen, deren anwendungen fuer in vitro-diagnostische zwecke und die herstellung von antigenzusammensetzungen.
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
DE3722967A1 (de) * 1987-07-11 1989-01-19 Behringwerke Ag Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung
JPS6461665A (en) * 1987-09-02 1989-03-08 Toa Nenryo Kogyo Kk Antibody to human papilloma virus antigen and method of using said antibody
US5180806A (en) * 1988-05-16 1993-01-19 The Scripps Research Institute Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods
SE8803870D0 (sv) * 1988-10-28 1988-10-28 Medscand Ab Method for detection of human papillomavirus (hpv) for diagnostic purposes
FR2641081A1 (da) * 1988-12-23 1990-06-29 Medgenix Group
DE3907721A1 (de) * 1989-03-10 1990-09-20 Behringwerke Ag Immunogene regionen auf dem e7-protein des humanen papillomvierus typ 16
IE902820A1 (en) * 1989-08-07 1991-02-27 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding¹to retinoblastoma gene proteins

Also Published As

Publication number Publication date
FI925098A0 (fi) 1992-11-10
AU668499B2 (en) 1996-05-09
CA2040849A1 (en) 1992-10-20
FI925098L (fi) 1992-11-10
CA2082658A1 (en) 1991-11-12
DE69128152D1 (de) 1997-12-11
AU7889091A (en) 1991-12-10
JPH06501542A (ja) 1994-02-17
FI925098A7 (fi) 1992-11-10
WO1991018294A1 (en) 1991-11-28
EP0594613A1 (en) 1994-05-04
SE9001705D0 (sv) 1990-05-11
ATE160020T1 (de) 1997-11-15
EP0594613B1 (en) 1997-11-05
DE69128152T2 (de) 1998-03-05

Similar Documents

Publication Publication Date Title
DK0594613T3 (da) Syntetiske peptider fra human papillomavirus 1, 6, 11, 16, 31, 33 og 56, der er nyttige i immunoassays til diagnostiske formål
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
DE69127487D1 (de) Verfahren zum Nachweis der Alzheimer-Krankheit
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
FI913891A7 (fi) Uusi monoklonaalinen vasta-aine uutta antigeenia vastaan, joka liittyy ihmisen kasvaimiin
NO932102L (no) Oligosakkarid avledet fra antigent polysakkarid erholdt fra et patogen
NO981133L (no) Ikke-reseptormedierte kontrastmidler
FI913560A7 (fi) Synteettiset peptidit, erikoisesti HCV:n vasta-aineiden havaitsemiseen, HCV infektion diagnoosiin ja sen estämiseen rokotteina
FR2628021B1 (fr) Appareil de scellement actionne par l'energie de la poudre
DE69017370D1 (de) Röntgenuntersuchungsapparat.
AT366786B (de) Gasturbinenanlage, insbesondere fuer den 6.000 - 10.000 kw bereich
EP0678744A3 (en) Detection method for urinary carcinoma-associated antigens.
IT7828492A0 (it) Antigene per l'esame precoce di gravidanza e vaccino contraccettivo.
NO170810C (no) Monoklonalt antistoff av igm-klassen for bruk in vitro ogfremgangsmaate for in vitro deteksjon og diagnose av cancer eller cystisk fibrose
NO892073D0 (no) Anordning for gassoppsamling i aluminium-ovner.
FI902735A0 (fi) Monoklonal antikropp reaktiv foer en visst vidstraeckt i olika maenskoleukemi- och lymfomaceller foerekommande antigen och metoder foer dess anvaendning i diagnos och vaord.
OA09653A (en) Rubella peptides
BE888855A (fr) Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose, et preparations ainsi obtenues
FR2275635A1 (fr) Appareil de prelevement d'echantillons par forage
DE68919202D1 (de) Röntgenuntersuchungsgerät mit Einstellhilfskraft.
ES2005569A6 (es) Metodos para detectar la presencia del organismo twar y sus anticuerpos en una muestra biologica.
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
DE3860200D1 (de) Verfahren und mittel zur bekaempfung der kaffeeminiermotte, insbesondere der art perileucoptera coffeella.
EP0600000A4 (en) HEPATITIS C DETECTION TEST USING RECOMBINANT ANTIGENS OF THE NS5 REGION.
FI922710A0 (fi) Eliminering av aktiverade lymfocyter.